These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 7240749

  • 1. The membrane attack mechanism of complement: photolabeling reveals insertion of terminal proteins into target membrane.
    Hu VW, Esser AF, Podack ER, Wisnieski BJ.
    J Immunol; 1981 Jul; 127(1):380-6. PubMed ID: 7240749
    [Abstract] [Full Text] [Related]

  • 2. Membrane attack by complement.
    Podack ER, Tschopp J.
    Mol Immunol; 1984 Jul; 21(7):589-603. PubMed ID: 6379417
    [Abstract] [Full Text] [Related]

  • 3. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [Abstract] [Full Text] [Related]

  • 4. Transmembrane channel-formation by five complement proteins.
    Müller-Eberhard HJ.
    Biochem Soc Symp; 1985 Nov; 50():235-46. PubMed ID: 2428370
    [Abstract] [Full Text] [Related]

  • 5. Deviated lysis: transfer of complement lytic activity to unsensitized cells. I. Generation of the transferable activity on the surface of complement resistant bacteria.
    Rother U, Hänsch G, Menzel J, Rother K.
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):172-86. PubMed ID: 4283273
    [No Abstract] [Full Text] [Related]

  • 6. Deviated lysis: transfer of complement lytic activity to unsensitized cells. IV. Parital isolation of the activity.
    Hänsch G, Rother U, Rother K.
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):48-59. PubMed ID: 868206
    [Abstract] [Full Text] [Related]

  • 7. Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement.
    Stewart JL, Kolb WP, Sodetz JM.
    J Immunol; 1987 Sep 15; 139(6):1960-4. PubMed ID: 3624872
    [Abstract] [Full Text] [Related]

  • 8. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
    Tschopp J, Chonn A, Hertig S, French LE.
    J Immunol; 1993 Aug 15; 151(4):2159-65. PubMed ID: 8345200
    [Abstract] [Full Text] [Related]

  • 9. Membrane attack complex of complement: generation of high-affinity phospholipid binding sites by fusion of five hydrophilic plasma proteins.
    Podack ER, Biesecker G, Müller-Eberhard HJ.
    Proc Natl Acad Sci U S A; 1979 Feb 15; 76(2):897-901. PubMed ID: 284414
    [Abstract] [Full Text] [Related]

  • 10. Evidence for a two-domain structure of the terminal membrane C5b-9 complex of human complement.
    Bhakdi S, Tranum-Jensen J.
    Proc Natl Acad Sci U S A; 1979 Nov 15; 76(11):5872-6. PubMed ID: 293689
    [Abstract] [Full Text] [Related]

  • 11. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
    Brannen CL, Sodetz JM.
    Mol Immunol; 2007 Feb 15; 44(5):960-5. PubMed ID: 16624411
    [Abstract] [Full Text] [Related]

  • 12. Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.
    Shin ML, Hänsch G, Hu VW, Nicholson-Weller A.
    J Immunol; 1986 Mar 01; 136(5):1777-82. PubMed ID: 2419414
    [Abstract] [Full Text] [Related]

  • 13. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH, Hänsch G, Gresham HD, Shin ML.
    J Immunol; 1983 Aug 01; 131(2):892-8. PubMed ID: 6863934
    [Abstract] [Full Text] [Related]

  • 14. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.
    Joiner KA, Hammer CH, Brown EJ, Frank MM.
    J Exp Med; 1982 Mar 01; 155(3):809-19. PubMed ID: 6801180
    [Abstract] [Full Text] [Related]

  • 15. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT, Austen KF, Ruddy S.
    Rheumatology; 1975 Mar 01; 6():2-16. PubMed ID: 1105744
    [No Abstract] [Full Text] [Related]

  • 16. [Complement activation and biological activities].
    Inoue K.
    Nihon Saikingaku Zasshi; 1976 Jul 01; 31(4):535-55. PubMed ID: 988219
    [No Abstract] [Full Text] [Related]

  • 17. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
    Kochi SK, Johnson RC, Dalmasso AP.
    J Immunol; 1991 Jun 01; 146(11):3964-70. PubMed ID: 2033266
    [Abstract] [Full Text] [Related]

  • 18. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
    Bhakdi S, Tranum-Jensen J.
    J Immunol; 1986 Apr 15; 136(8):2999-3005. PubMed ID: 3958488
    [Abstract] [Full Text] [Related]

  • 19. Complement component C7 is a plasminogen-binding protein.
    Reinartz J, Hänsch GM, Kramer MD.
    J Immunol; 1995 Jan 15; 154(2):844-50. PubMed ID: 7814888
    [Abstract] [Full Text] [Related]

  • 20. The C5b-9 complex: subunit composition of the classical and alternative pathway-generated complex.
    Podack ER, Kolb WP, Muller-Eberhard HJ.
    J Immunol; 1976 May 15; 116(5):1431-4. PubMed ID: 1270802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.